Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cyp2c44 Inhibitors

Cyp2c44 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the Cyp2c44 enzyme, a member of the cytochrome P450 superfamily. Cyp2c44 is involved in the metabolism of a diverse range of substrates, including endogenous molecules such as fatty acids, eicosanoids, and other signaling lipids, as well as exogenous compounds like drugs and environmental chemicals. The enzyme plays a critical role in the oxidative metabolism process, where it catalyzes the insertion of an oxygen atom into its substrates, typically converting lipophilic molecules into more hydrophilic forms. This oxidation process is essential for the subsequent metabolism, conjugation, or excretion of these molecules, thereby contributing to the detoxification and regulatory processes within the body. Cyp2c44's activity is particularly significant in the liver and kidneys, where it helps maintain homeostasis by modulating the levels of bioactive lipids and other compounds.

Inhibitors of Cyp2c44 are typically small molecules that bind to the enzyme's active site, thereby preventing it from catalyzing the oxidation of its substrates. These inhibitors may function by occupying the substrate-binding pocket, effectively blocking the natural substrates from accessing the catalytic core, or by inducing conformational changes that reduce the enzyme's catalytic efficiency. The design and development of Cyp2c44 inhibitors involve a detailed understanding of the enzyme's structure, particularly the regions critical for substrate binding and enzymatic activity. By inhibiting Cyp2c44, researchers can investigate the enzyme's specific role in lipid metabolism and other related pathways, providing insights into how the modulation of Cyp2c44 affects the broader network of metabolic processes. The study of Cyp2c44 inhibitors is important for understanding the enzyme's role in the regulation of bioactive lipid levels and its impact on various physiological functions. This research contributes to a broader comprehension of the cytochrome P450 family's roles in metabolism, highlighting the intricate balance these enzymes maintain in processing both endogenous and exogenous compounds within biological systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Flavonoids are competitive inhibitors of CYP2C9, blocking the enzyme's active site and thereby reducing its activity.

Amiodarone

1951-25-3sc-480089
5 g
$318.00
(1)

While amiodarone primarily inhibits CYP3A4, it also inhibits CYP2C9. It reduces the metabolism of drugs metabolized by CYP2C9.

Ticlopidine Hydrochloride

53885-35-1sc-205861
sc-205861A
1 g
5 g
$32.00
$99.00
2
(1)

Inhibits CYP2C9, leading to reduced metabolism of warfarin and other drugs that are substrates of this enzyme.

Fluconazole

86386-73-4sc-205698
sc-205698A
500 mg
1 g
$54.00
$84.00
14
(1)

Potent inhibitor of CYP2C9, CYP2C19, and CYP3A4. It competitively inhibits the active site of these enzymes.

Miconazole

22916-47-8sc-204806
sc-204806A
1 g
5 g
$66.00
$160.00
2
(1)

Topical antifungal that inhibits several cytochrome P450 enzymes, including CYP2C9. It competes with substrates for binding.